Nerve growth factor and neurological illnesses;Factor de crecimiento nervioso y enfermedades neurologicas

Revista de Neurologia

Volumn 26, Issue 153, 1998, Pages 744-748

  Lorigados, L ^a  

^a CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Huntington's chorea; Immuno enzymatic assay; Multiple sclerosis; Nerve growth factor; Parkinson's disease; Serum

Indexed keywords

NERVE GROWTH FACTOR;

ADULT; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; NERVE GROWTH; PARKINSON DISEASE; PROTEIN DETERMINATION;

EID: 0032293502     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.26153.98023     Document Type: Article

References (20)

1. Levi-Montalcini E. Nerve growth factor. Physiol Rev 1968; 48: 534-69.
2. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154-62.
3. Thoenen H, Barde Y-A. Physiology of nerve growth factor. Physiol Rev 1980; 60: 1284-335.
4. Thoenen H, Bandtlow C, Heumann R. The physiological function of nerve growth factor in the central nervous system: Comparison with the periphery. Rev Physiol Biochem Pharmacol 1987; 109: 145-78.
5. Ebendal T. NGF in CNS: Experimental data and clinical implications. Prog Growth Factor Res 1989; 1: 143-9.
6. Hefti F, Weiner WJ. Nerve growth factor and Alzheimer's disease. Ann Neurol 1986; 20: 275-81.
7. Williams LR, Varon S, Peterson GF, Wictorin K, Björklund A, Gage FH. Continuos infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transection. Proc Natl Acad Sci USA 1986; 88: 9231-5.
8. Olson L, Backlumd E-O, Ebendal T, Freedman R, Hamberger B, Hansson P, et al. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease: One-years-follow-up of first clinical trial. Arch Neurol 1991; 48: 373-81.
9. Lorigados L, Söderstrom S, Ebendal T. Two-site enzyme immunoassay for β-NGF applied to human patient sera. J Neurosci Res 1992; 32: 329-33.
10. 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect 1992; 4: 79-95.
11. Richardson PM, Verge Issa VMK, Riopelle RJ. Distribution of neuronal receptors for nerve growth factors in the rat. J Neurosci 1986; 6: 2312-21.
12. Furukawa S, Kamo I, Furukawa Y, Akazawa S, Satoyoshi E, Itoh K, et al. A highly sensitive enzyme immunoassay for mouse β nerve growth factor. J Neurochem 1983; 40: 734-44.
13. Lärkfors L, Ebendal T. Highly sensitive enzymen immunoassay for β-nerve growth factor. J Immunol Methods 1987; 97: 41-7.
14. Korsching S, Thoenen H. Two-site enzyme immunoassay for the nerve growth factor. Methods Enzymol 1987; 147: 167-85.
15. Johnson DG, Gorden P, Kopin J. A sensitive radioimmunoassay for 7S nerve growth factor antigents in serum and tissues. J Neurochem 1971; 18: 2355-62.
16. Fabricant RN, Todaro G. Increased serum levels of nerve growth factor in von Recklinghausen's disease. Arch Neurol 1981; 38: 401-5.
17. Skaper SD, Varon S. Three independent biological assay for nerve growth factor: No measurable activity in human sera. Exp Neurol 1982; 76: 655-65.
18. Heinrich G, Meyer TE. Nerve growth factor is present in human placenta and semen but undetectable in normal and Paget's disease blood: Measurements with an anti-mousc-NGF enzyme immunoassay using a recombinant human NGF reference. Biochem Biophys Res Commun 1988; 155: 482-6.
19. Stephani U, Murer K. Nerve growth factor in serum of patients with dementia (Alzheimer type). In Maurer K, et al, eds. Alzheimer's disease. Wien: Springer Verlag; 1990. p. 324-7.
20. Dicou E, Huolgatte E, Lee J, von Wilcken-Bergmann. Synthesis of chimeric mouse nerve growth factor precursor and human β-nerve growth factor in Escherichia coli: Immunological properties. J Neurosci 1989; 22: 13-9.